Machine learning-based models for genomic predicting neoadjuvant chemotherapeutic sensitivity in cervical cancer

Lu Guo, Wei Wang, Xiaodong Xie, Shuihua Wang, Yudong Zhang*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

Background: The PI3K/Akt pathway involves in regulating resistance to platinum-based neoadjuvant chemotherapy (NACT) in locally advanced cervical cancer (LACC) patients. Single nucleotide polymorphisms (SNPs) reflect the basic genetic variation between individuals. Random forest (RF) is one of the machine-learning models that can predict drug sensitivity with high accuracy. We applied the RF model for genomic prediction of NACT sensitivity in LACC patients. Materials and Methods: A total of 259 LACC patients were separated to two groups (i) effective and (ii) ineffective NACT group, depending on the NACT response. The 24 SNPs in four genes (PTEN, PIK3CA, Akt1, and Akt2) were genotyped by the Sequenom MassArray system in these patients. We implemented the SNPs as the feature to train the RF model, calculated the feature importance using mean decreases in impurity based on the model, and further analyzed the importance of each SNP. Results: The importance analysis indicated that the top three SNPs (rs4558508, rs1130233, and rs7259541) and the last six loci (rs892120, rs62107593, rs34716810, rs10416620, rs41275748, and rs41275746) were all located in Akt. The patients carrying heterozygous GA in Akt2 rs4558508 had a considerably higher risk of chemoresistance than those carrying GG or AA genotype. Conclusion: The RF model could accurately predict the response to platinum-based NACT of LACC patients. The variables of Akt2 rs4558508 and rs7259541, and Akt1 rs1130233 were major polymorphic loci for NACT inefficiency. The LACC patients carrying heterozygous GA of Akt2 rs4558508 had a significantly increased risk of chemoresistance. Akt was an important gene in PI3K/Akt pathway that could predict the response of platinum-based NACT. The study applied the basis for an individualized approach to LACC patient therapy.

Original languageEnglish
Article number114256
JournalBiomedicine and Pharmacotherapy
Volume159
DOIs
Publication statusPublished - Mar 2023
Externally publishedYes

Keywords

  • Chemosensitivity
  • Locally advanced cervical cancer
  • Machine learning
  • Neoadjuvant chemotherapy
  • Random forest
  • Single nucleotide polymorphisms

Fingerprint

Dive into the research topics of 'Machine learning-based models for genomic predicting neoadjuvant chemotherapeutic sensitivity in cervical cancer'. Together they form a unique fingerprint.

Cite this